Enhanced Prediction and Characterization of CDK Inhibitors Using Optimal Class Distribution

Abhigyan Nath1, S Karthikeyan2

  • 1Department of Computer Science, Banaras Hindu University, Varanasi, 221005, India. abhigyannath01@gmail.com.

Insights

Machine learning models can accurately predict cyclin-dependent kinase inhibitors (CDKIs) by optimizing training data class distribution. This approach enhances prediction performance for these crucial cell cycle regulators.

Area of Science:

  • Biochemistry and Molecular Biology
  • Computational Biology and Bioinformatics

Background:

  • Cyclin-dependent kinase inhibitors (CDKIs) are critical regulators of cell cycle progression, involved in tumor suppression and apoptosis.
  • Traditional sequence similarity methods struggle to identify CDKIs due to their sequence diversity.
  • Machine learning (ML) offers a promising alternative for accurate CDKI prediction.

Purpose of the Study:

  • To develop and evaluate a framework for enhancing ML-based CDKI prediction by addressing class imbalance.
  • To investigate optimal class distribution ratios, sampling techniques (oversampling/undersampling), and classifier selection for improved prediction.

Main Methods:

  • Implemented and compared ML models using imbalanced and resampled training datasets.
  • Utilized Synthetic Minority Over-sampling Technique (SMOTE) and undersampling to create varied class distributions.
  • Evaluated model performance using metrics including sensitivity, specificity, accuracy, MCC, and AUC.

Main Results:

  • The proposed framework achieved 100% sensitivity, 93.7% specificity, 96.4% accuracy, 0.929 MCC, and 0.981 AUC.
  • Optimal class distribution in training sets significantly enhanced ML model performance.
  • The model demonstrated strong generalization on independent blind testing sets.

Conclusions:

  • Optimizing class distribution in training data is a key strategy for improving ML-based CDKI prediction.
  • The developed framework effectively handles class imbalance, leading to highly accurate CDKI identification.
  • This work provides a valuable learning enhancement parameter for ML prediction models in biological datasets.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310